Хайлтын үр дүнгүүд - Wang, Aoli
- 23-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
-
2
Discovery of a highly potent and selective Bruton’s tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma -н Liu, Juan, Liang, Qianmao, Wang, Aoli, Zou, Fengming, Qi, Ziping, Yu, Kailin, Liu, Qingwang, Chen, Cheng, Liu, Jing, Liu, Qingsong
Хэвлэсэн 2020текст -
3
Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia -н Hu, Chen, Zou, Fengming, Wang, Aoli, Miao, Weili, Liang, Qianmao, Weisberg, Ellen L., Wang, Yinsheng, Liu, Jing, Wang, Wenchao, Liu, Qingsong
Хэвлэсэн 2021текст -
4
-
5
Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders -н Jiang, Hua, He, Hongbin, Chen, Yun, Huang, Wei, Cheng, Jinbo, Ye, Jin, Wang, Aoli, Tao, Jinhui, Wang, Chao, Liu, Qingsong, Jin, Tengchuan, Jiang, Wei, Deng, Xianming, Zhou, Rongbin
Хэвлэсэн 2017текст -
6
Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent -н Jiang, Zongru, Wang, Li, Liu, Xuesong, Chen, Cheng, Wang, Beilei, Wang, Wenliang, Hu, Chen, Yu, Kailin, Qi, Ziping, Liu, Qingwang, Wang, Aoli, Liu, Jing, Hong, Guangchen, Wang, Wenchao, Liu, Qingsong
Хэвлэсэн 2020текст -
7
Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib‐induced KIT mutations in gastrointestinal stromal tumours -н Liu, Juan, Gao, Jingjing, Wang, Aoli, Jiang, Zongru, Qi, Shuang, Qi, Ziping, Liu, Feiyang, Yu, Kailin, Cao, Jiangyan, Chen, Cheng, Hu, Chen, Wu, Hong, Wang, Li, Wang, Wenchao, Liu, Qingsong, Liu, Jing
Хэвлэсэн 2022текст -
8
Ibrutinib Selectively Targets FLT3-ITD in Mutant FLT3-Positive AML -н Wu, Hong, Hu, Chen, Wang, Aoli, Weisberg, Ellen L., Wang, Wenchao, Chen, Cheng, Zhao, Zheng, Yu, Kailin, Liu, Juan, Wu, Jiaxin, Nonami, Atsushi, Wang, Li, Wang, Beilei, Stone, Richard M., Liu, Suiyang, Griffin, James D., Liu, Jing, Liu, Qingsong
Хэвлэсэн 2015текст -
9
Selectively targeting FLT3-ITD mutants over FLT3- wt by a novel inhibitor for acute myeloid leukemia -н Wang, Aoli, Hu, Chen, Chen, Cheng, Liang, Xiaofei, Wang, Beilei, Zou, Fengming, Yu, Kailin, Li, Feng, Liu, Qingwang, Qi, Ziping, Wang, Junjie, Wang, Wenliang, Wang, Li, Weisberg, Ellen L., Wang, Wenchao, Li, Lili, Ge, Jian, Xia, Ruixiang, Liu, Jing, Liu, Qingsong
Хэвлэсэн 2020текст -
10
Discovery and characterization of a novel irreversible EGFR mutants selective and potent kinase inhibitor CHMFL-EGFR-26 with a distinct binding mode -н Hu, Chen, Wang, Aoli, Wu, Hong, Qi, Ziping, Li, Xixiang, Yan, Xiao-E, Chen, Cheng, Yu, Kailin, Zou, Fengming, Wang, Wenchao, Wang, Wei, Wu, Jiaxin, Liu, Juan, Wang, Beilei, Wang, Li, Ren, Tao, Zhang, Shanchun, Yun, Cai-Hong, Liu, Jing, Liu, Qingsong
Хэвлэсэн 2017текст -
11
Discovery of a highly selective KIT kinase primary V559D mutant inhibitor for gastrointestinal stromal tumors (GISTs) -н Yu, Kailin, Liu, Xuesong, Jiang, Zongru, Hu, Chen, Zou, Fengming, Chen, Cheng, Ge, Juan, Wu, Jiaxin, Liu, Xiaochuan, Wang, Aoli, Wang, Wenliang, Wang, Wenchao, Qi, Ziping, Wang, Beilei, Wang, Li, Yan, Hezhong, Wang, Jiaoxue, Ren, Tao, Tang, Jun, Liu, Qingsong, Liu, Jing
Хэвлэсэн 2017текст -
12
Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia... -н Wu, Jiaxin, Wang, Aoli, Li, Xixiang, Chen, Cheng, Qi, Ziping, Hu, Chen, Wang, Wenliang, Wu, Hong, Huang, Tao, Zhao, Ming, Wang, Wenchao, Hu, Zhenquan, Liu, Qingwang, Wang, Beilei, Wang, Li, Li, Lili, Ge, Jian, Ren, Tao, Xia, Ruixiang, Liu, Jing, Liu, Qingsong
Хэвлэсэн 2019текст -
13
Ibrutinib targets mutant-EGFR kinase with a distinct binding conformation -н Wang, Aoli, Yan, Xiao-E, Wu, Hong, Wang, Wenchao, Hu, Chen, Chen, Cheng, Zhao, Zheng, Zhao, Peng, Li, Xixiang, Wang, Li, Wang, Beilei, Ye, Zi, Wang, Jinhua, Wang, Chu, Zhang, Wei, Gray, Nathanael S., Weisberg, Ellen L., Chen, Liang, Liu, Jing, Yun, Cai-Hong, Liu, Qingsong
Хэвлэсэн 2016текст -
14
Irreversible inhibition of BTK kinase by a novel highly selective inhibitor CHMFL-BTK-11 suppresses inflammatory response in rheumatoid arthritis model -н Wu, Hong, Huang, Qiong, Qi, Ziping, Chen, Yongfei, Wang, Aoli, Chen, Cheng, Liang, Qianmao, Wang, Jinghua, Chen, Wensheng, Dong, Jin, Yu, Kailin, Hu, Chen, Wang, Wenchao, Liu, Xiaochuan, Deng, Yuanxin, Wang, Li, Wang, Beilei, Li, Xiaoxiang, Gray, Nathanael S., Liu, Jing, Wei, Wei, Liu, Qingsong
Хэвлэсэн 2017текст -
15
Dual inhibition of AKT/FLT3-ITD by A674563 overcomes FLT3 ligand-induced drug resistance in FLT3-ITD positive AML -н Wang, Aoli, Wu, Hong, Chen, Cheng, Hu, Chen, Qi, Ziping, Wang, Wenchao, Yu, Kailin, Liu, Xiaochuan, Zou, Fengming, Zhao, Zheng, Wu, Jiaxin, Liu, Juan, Liu, Feiyang, Wang, Li, Stone, Richard M., Galinksy, Ilene A., Griffin, James D., Zhang, Shanchun, Weisberg, Ellen L., Liu, Jing, Liu, Qingsong
Хэвлэсэн 2016текст -
16
Discovery and characterization of a novel potent type II native and mutant BCR-ABL inhibitor (CHMFL-074) for Chronic Myeloid Leukemia (CML) -н Liu, Feiyang, Wang, Beilei, Wang, Qiang, Qi, Ziping, Chen, Cheng, Kong, Lu-Lu, Chen, Ji-Yun, Liu, Xiaochuan, Wang, Aoli, Hu, Chen, Wang, Wenchao, Wang, Huiping, Wu, Fan, Ruan, Yanjie, Qi, Shuang, Liu, Juan, Zou, Fengming, Hu, Zhenquan, Wang, Wei, Wang, Li, Zhang, Shanchun, Yun, Cai-Hong, Zhai, Zhimin, Liu, Jing, Liu, Qingsong
Хэвлэсэн 2016текст -
17
Discovery of a Potent, Covalent BTK Inhibitor for B-Cell Lymphoma -н Wu, Hong, Wang, Wenchao, Liu, Feiyang, Weisberg, Ellen L., Tian, Bei, Chen, Yongfei, Li, Binhua, Wang, Aoli, Wang, Beilei, Zhao, Zheng, McMillin, Douglas W., Hu, Chen, Li, Hong, Wang, Jinhua, Liang, Yanke, Buhrlage, Sara J., Liang, Junting, Liu, Jing, Yang, Guang, Brown, Jennifer R., Treon, Steven P., Mitsiades, Constantine S., Griffin, James D., Liu, Qingsong, Gray, Nathanael S.
Хэвлэсэн 2014текст -
18
Discovery of a Highly Potent FLT3 Kinase Inhibitor for FLT3-ITD-Positive AML -н Wu, Hong, Wang, Aoli, Qi, Ziping, Li, Xixiang, Chen, Cheng, Yu, Kailin, Zou, Fengming, Hu, Chen, Wang, Wenchao, Zhao, Zheng, Wu, Jiaxin, Liu, Juan, liu, Xiaochuan, Wang, Li, Wang, Wei, Zhang, Shanchun, Stone, Richard M., Galinsky, Ilene A., Griffin, James D., Weinstock, David, Christodoulou, Alexandra, Wang, Huiping, Shen, Yuanyuan, Zhai, Zhimin, Weisberg, Ellen L., Liu, Jing, Liu, Qingsong
Хэвлэсэн 2016текст -
19
Characterization of selective and potent PI3Kδ inhibitor (PI3KD-IN-015) for B-Cell malignances -н Liu, Xiaochuan, Wang, Aoli, Liang, Xiaofei, Chen, Cheng, Liu, Juanjuan, Zhao, Zheng, Wu, Hong, Deng, Yuanxin, Wang, Li, Wang, Beilei, Wu, Jiaxin, Liu, Feiyang, Fernandes, Stacey M., Adamia, Sophia, Stone, Richard M., Galinsky, Ilene A., Brown, Jennifer R., Griffin, James D., Zhang, Shanchun, Loh, Teckpeng, Zhang, Xin, Wang, Wenchao, Weisberg, Ellen L., Liu, Jing, Liu, Qingsong
Хэвлэсэн 2016текст -
20
Simultaneous inhibition of Vps34 kinase would enhance PI3Kδ inhibitor cytotoxicity in the B-cell malignancies -н Liu, Xiaochuan, Wang, Aoli, Liang, Xiaofei, Liu, Juanjuan, Zou, Fengming, Chen, Cheng, Zhao, Zheng, Deng, Yuanxin, Wu, Hong, Qi, Ziping, Wang, Beilei, Wang, Li, Liu, Feiyang, Xu, Yunhe, Wang, Wenchao, Fernandes, Stacey M., Stone, Richard M., Galinsky, Ilene A., Brown, Jennifer R., Loh, Teckpeng, Griffin, James. D., Zhang, Shanchun, Weisberg, Ellen L., Zhang, Xin, Liu, Jing, Liu, Qingsong
Хэвлэсэн 2016текст